SAM
PBYI icon

Storebrand Asset Management’s Puma Biotechnology PBYI Stock Holding History

Storebrand Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,650
Closed -$24.3K – 849
2021
Q2 		$24.3K Hold
2,650
– – ﹤0.01% 828
2021
Q1 		$25.8K Hold
2,650
– – ﹤0.01% 809
2020
Q4 		$27.2K Hold
2,650
– – ﹤0.01% 818
2020
Q3 		$26.7K Sell
2,650
-266
-9% -$2.71K ﹤0.01% 787
2020
Q2 		$30.4K Hold
2,916
– – ﹤0.01% 799
2020
Q1 		$24.6K Buy
+2,916
New +$28.3K ﹤0.01% 788

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Storebrand Asset Management's PBYI Position: Q3 2021 in Review

Storebrand Asset Management sold out of Puma Biotechnology (PBYI) in Q3 2021, closing a stake of 2,650 shares — an estimated $24.3K sold.

Storebrand Asset Management first reported a position in PBYI in Q1 2020 and held it in 6 quarters. The position peaked at $30.4K in Q2 2020. 115 funds tracked by Wall St. Rank hold PBYI as of Q3 2021.

  • Storebrand Asset Management reported no remaining Puma Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Storebrand Asset Management sold 2,650 Puma Biotechnology shares in Q3 2021, an estimated $24.3K.
  • Storebrand Asset Management first reported a position in Puma Biotechnology in Q1 2020 and held it in 6 quarters.
  • Storebrand Asset Management's Puma Biotechnology position peaked at $30.4K in Q2 2020.
  • 115 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2021.

Based on Storebrand Asset Management's 13F filing for Q3 2021, filed 18 Jun 2026.